We are live on
!
Find out more
Oric Pharmaceuticals
ORIC
ORIC
122 hedge funds and large institutions have $715M invested in Oric Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 39 increasing their positions, 38 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,838% more call options, than puts
Call options by funds: $155K | Put options by funds: $8K
85% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 13
50% more capital invested
Capital invested by funds: $478M → $715M (+$237M)
9% more funds holding
Funds holding: 112 → 122 (+10)
3% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 38
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
1.25% less ownership
Funds ownership: 100.23% → 98.98% (-1.2%)
Holders
122
Holders Change
+10
Holders Change %
+8.93%
% of All Funds
1.75%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
24
Increased
39
Reduced
38
Closed
13
Calls
$155K
Puts
$8K
Net Calls
+$147K
Net Calls Change
+$96K
Top Buyers
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$14.3M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$11.2M |
| 3 |
SCM
Superstring Capital Management
New York
|
+$9.39M |
| 4 |
BlackRock
New York
|
+$2.68M |
| 5 |
Charles Schwab
San Francisco,
California
|
+$2.45M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.35M |
| 2 |
Millennium Management
New York
|
-$4.83M |
| 3 |
State Street
Boston,
Massachusetts
|
-$3.14M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$2.03M |
| 5 |
O
OrbiMed
New York
|
-$2.03M |
